MedPath

BROMAZEPAM PENSA 3 mg CAPSULAS EFG

BROMAZEPAM PENSA 3 mg CAPSULAS EFG

Commercialized
Register Number

73319

Prescription Type

Medicamento Sujeto A Prescripción Médica. Psicótropos

Authorization Date

Jan 23, 2011

Dosage Form

CÁPSULA DURA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number73319
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BROMAZEPAMActive
Quantity: 3 mg
Name: BROMAZEPAM

ATC CLASSIFICATION (3)

N05B
N05BA
N05BA08

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.